PL3054920T3 - Inhalator suchego proszku - Google Patents

Inhalator suchego proszku

Info

Publication number
PL3054920T3
PL3054920T3 PL14786419T PL14786419T PL3054920T3 PL 3054920 T3 PL3054920 T3 PL 3054920T3 PL 14786419 T PL14786419 T PL 14786419T PL 14786419 T PL14786419 T PL 14786419T PL 3054920 T3 PL3054920 T3 PL 3054920T3
Authority
PL
Poland
Prior art keywords
dry powder
powder inhaler
inhaler
dry
powder
Prior art date
Application number
PL14786419T
Other languages
English (en)
Inventor
Mukul Dalvi
Seah Kee Tee
Original Assignee
Teva Branded Pharmaceutical Products R&D, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51743574&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3054920(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Branded Pharmaceutical Products R&D, Inc. filed Critical Teva Branded Pharmaceutical Products R&D, Inc.
Publication of PL3054920T3 publication Critical patent/PL3054920T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/001—Particle size control
    • A61M11/002—Particle size control by flow deviation causing inertial separation of transported particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0005—Details of inhalators; Constructional features thereof with means for agitating the medicament
    • A61M15/0006—Details of inhalators; Constructional features thereof with means for agitating the medicament using rotating means
    • A61M15/0008—Details of inhalators; Constructional features thereof with means for agitating the medicament using rotating means rotating by airflow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0021—Mouthpieces therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0021—Mouthpieces therefor
    • A61M15/0025—Mouthpieces therefor with caps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
    • A61M15/007—Mechanical counters
    • A61M15/0071—Mechanical counters having a display or indicator
    • A61M15/0076—Mechanical counters having a display or indicator on a drum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0086—Inhalation chambers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0021—Mouthpieces therefor
    • A61M15/0025—Mouthpieces therefor with caps
    • A61M15/0026—Hinged caps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
    • A61M15/007—Mechanical counters
    • A61M15/0071—Mechanical counters having a display or indicator
    • A61M15/0078—Mechanical counters having a display or indicator on a strip
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2206/00—Characteristics of a physical parameter; associated device therefor
    • A61M2206/10—Flow characteristics
    • A61M2206/16—Rotating swirling helical flow, e.g. by tangential inflows

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL14786419T 2013-10-07 2014-10-06 Inhalator suchego proszku PL3054920T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361887589P 2013-10-07 2013-10-07
US201361888301P 2013-10-08 2013-10-08
EP14786419.3A EP3054920B1 (en) 2013-10-07 2014-10-06 Dry powder inhaler
PCT/US2014/059285 WO2015054124A2 (en) 2013-10-07 2014-10-06 Dry powder inhaler

Publications (1)

Publication Number Publication Date
PL3054920T3 true PL3054920T3 (pl) 2021-07-05

Family

ID=51743574

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14786419T PL3054920T3 (pl) 2013-10-07 2014-10-06 Inhalator suchego proszku

Country Status (23)

Country Link
US (2) US9066957B2 (pl)
EP (1) EP3054920B1 (pl)
JP (1) JP6543620B2 (pl)
KR (1) KR102364945B1 (pl)
CN (1) CN105636630B (pl)
AU (1) AU2014332191B2 (pl)
BR (1) BR112016007771B1 (pl)
CA (1) CA2926432A1 (pl)
CL (1) CL2016000735A1 (pl)
DK (1) DK3054920T3 (pl)
EA (1) EA035329B1 (pl)
ES (1) ES2863198T3 (pl)
HK (1) HK1222127A1 (pl)
HU (1) HUE055042T2 (pl)
IL (1) IL244959B (pl)
MX (1) MX374870B (pl)
PE (1) PE20160543A1 (pl)
PH (1) PH12016500619B1 (pl)
PL (1) PL3054920T3 (pl)
PT (1) PT3054920T (pl)
TW (1) TWI673070B (pl)
WO (1) WO2015054124A2 (pl)
ZA (1) ZA201601960B (pl)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013036881A2 (en) 2011-09-07 2013-03-14 Syphase, Llc Dry powder inhalation device
PL3054920T3 (pl) * 2013-10-07 2021-07-05 Teva Branded Pharmaceutical Products R&D, Inc. Inhalator suchego proszku
AU356105S (en) * 2013-11-29 2014-06-24 Norton Waterford Ltd Respiratory apparatus
USD769436S1 (en) * 2013-11-29 2016-10-18 Norton (Waterford) Limited Respiratory apparatus
USD755367S1 (en) * 2014-03-10 2016-05-03 Civitas Therapeutics, Inc. Indicator for an inhaler
USD752204S1 (en) * 2014-03-10 2016-03-22 Civitas Therapeutics, Inc. Indicator for an inhaler
USD752734S1 (en) 2014-03-10 2016-03-29 Civitas Therapeutics, Inc. Inhaler grip
MA41378A (fr) * 2015-01-20 2017-11-28 Teva Branded Pharmaceutical Prod R & D Inc Inhalateur de poudre sèche comprenant du propionate de fluticasone et du xinafoate de salmétérol
CN107095875B (zh) * 2016-02-23 2022-03-18 天津金耀集团有限公司 一种昔奈酸沙美特罗丙酸氟替卡松复方粉吸入剂组合物
CN109562236B (zh) * 2016-04-12 2022-04-26 生物合作制造公司 定量雾化吸入器附加设备，观察改善系统以及改善使用定量雾化吸入器中的观察的方法
CN106267484A (zh) * 2016-08-08 2017-01-04 中山市美捷时包装制品有限公司 一种干粉吸入装置的定量供料机构
USD852947S1 (en) * 2016-10-21 2019-07-02 Norton (Waterford) Limited Inhaler
USD832997S1 (en) * 2016-10-21 2018-11-06 Norton (Waterford) Limited Inhaler
USD832998S1 (en) * 2016-10-21 2018-11-06 Norton (Waterford) Limited Inhaler
EP3552646B1 (en) * 2016-11-18 2021-07-07 Norton (Waterford) Limited Drug delivery device with electronics
USD853555S1 (en) * 2017-01-03 2019-07-09 Norton (Waterford) Limited Inhaler
GB201700727D0 (en) * 2017-01-16 2017-03-01 Teva Pharma Inhalers and airflow adaptors therefor
CA3057683A1 (en) 2017-03-28 2018-10-04 Concentrx Pharmaceuticals, Inc. Devices and methods for delivering dry powder medicaments
CN107715264B (zh) * 2017-10-12 2021-01-29 上海新黄河制药有限公司 一种粉雾剂装置制剂粉末团聚物的分散/解聚装置
CN107737393B (zh) * 2017-10-12 2020-08-28 上海新黄河制药有限公司 一种用于粉雾剂吸入装置的制剂雾化流道
CN111542308B (zh) 2017-12-13 2024-04-02 埃姆弗西斯进出口及分销有限公司 干粉吸入器
USD949323S1 (en) * 2019-07-26 2022-04-19 Lupin Ltd. Inhaler
USD949324S1 (en) * 2019-07-26 2022-04-19 Lupin Ltd. Inhaler
USD948703S1 (en) * 2019-07-26 2022-04-12 Lupin Ltd. Inhaler
USD948704S1 (en) * 2019-07-26 2022-04-12 Lupin Ltd. Inhaler
USD1006214S1 (en) * 2020-02-14 2023-11-28 Aptar France Sas Inhaler
USD1006213S1 (en) * 2020-02-14 2023-11-28 Aptar France Sas Inhaler
WO2021219535A1 (en) * 2020-04-27 2021-11-04 Jt International Sa Aerosol generation device
GB202012742D0 (en) * 2020-08-14 2020-09-30 Norton Waterford Ltd An inhalable medicament
KR102767525B1 (ko) 2022-01-24 2025-02-14 주식회사 케이티앤지 흡입기
KR102782140B1 (ko) 2022-08-25 2025-03-18 주식회사 케이티앤지 흡입기
KR102783650B1 (ko) 2022-09-14 2025-03-19 주식회사 케이티앤지 흡입기
KR102864455B1 (ko) 2022-09-14 2025-09-26 주식회사 케이티앤지 흡입기
KR102885446B1 (ko) 2022-09-19 2025-11-14 주식회사 케이티앤지 흡입기
KR102917969B1 (ko) 2022-12-30 2026-01-26 주식회사 케이티앤지 흡입기
WO2025012114A1 (en) 2023-07-07 2025-01-16 Norton (Waterford) Limited An inhalable formulation of fluticasone propionate and albuterol sulfate for the treatment of asthma
EP4487842A1 (en) 2023-07-07 2025-01-08 Norton (Waterford) Limited An inhalable formulation of fluticasone propionate and albuterol sulfate for the treatment of asthma
AU2024294145A1 (en) 2023-07-07 2025-12-04 Norton (Waterford) Limited An inhalable formulation of fluticasone propionate and albuterol sulfate for the treatment of asthma
WO2025199032A1 (en) * 2024-03-18 2025-09-25 Transpire Bio Inc. Trigger mechanism and powder inhalation device
EP4678170A1 (en) 2024-07-08 2026-01-14 Norton (Waterford) Limited A fixed-dose dry powder inhalation formulation of fluticasone propionate and albuterol sulfate for the treatment of asthma
WO2026013023A1 (en) 2024-07-08 2026-01-15 Norton (Waterford) Limited A fixed-dose dry powder inhalation formulation of fluticasone propionate and albuterol sulfate for the treatment of asthma

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395300B1 (en) * 1999-05-27 2002-05-28 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
TWI224513B (en) * 2000-06-23 2004-12-01 Norton Healthcare Ltd Dose counter for medicament inhaler
PE20020067A1 (es) * 2000-06-23 2002-02-05 Norton Healthcare Ltd Desaglomerador para inhalador de polvo seco accionado por la respiracion
GB0124523D0 (en) * 2001-10-12 2001-12-05 Glaxo Group Ltd Pharmaceutical combination
PT1386630E (pt) * 2002-07-31 2006-09-29 Chiesi Farma Spa Inalador em po
CN1694689A (zh) * 2002-09-30 2005-11-09 阿库斯菲尔公司 供吸入的缓释多孔微粒
HUE034380T2 (en) * 2007-04-30 2018-02-28 Sun Pharma Advanced Res Co Ltd Inhalation device
JP2008301847A (ja) * 2007-06-05 2008-12-18 Canon Inc 吸入装置及びその駆動方法
US20100329996A1 (en) * 2007-09-12 2010-12-30 Glaxo Group Limited Novel Combination of Therapeutic Agents
PT2435025T (pt) * 2009-05-29 2016-11-11 Pearl Therapeutics Inc Administração, por via respiratória, de agentes activos
GB0919465D0 (en) * 2009-11-06 2009-12-23 Norton Healthcare Ltd Airflow adaptor for a breath-actuated dry powder inhaler
WO2011145109A1 (en) * 2010-05-20 2011-11-24 Sun Pharma Advanced Research Company Ltd., Dry powder inhalation composition
PL3054920T3 (pl) * 2013-10-07 2021-07-05 Teva Branded Pharmaceutical Products R&D, Inc. Inhalator suchego proszku
MA41378A (fr) * 2015-01-20 2017-11-28 Teva Branded Pharmaceutical Prod R & D Inc Inhalateur de poudre sèche comprenant du propionate de fluticasone et du xinafoate de salmétérol

Also Published As

Publication number Publication date
PE20160543A1 (es) 2016-06-05
HUE055042T2 (hu) 2021-10-28
MX2016004316A (es) 2016-10-12
EP3054920B1 (en) 2021-03-03
MX374870B (es) 2025-03-06
IL244959B (en) 2020-11-30
HK1219444A1 (zh) 2017-04-07
EA035329B1 (ru) 2020-05-28
JP2016536043A (ja) 2016-11-24
IL244959A0 (en) 2016-05-31
NZ718315A (en) 2021-10-29
JP6543620B2 (ja) 2019-07-10
AU2014332191B2 (en) 2020-04-02
EA201690738A1 (ru) 2016-08-31
HK1222127A1 (zh) 2017-06-23
PT3054920T (pt) 2021-03-23
AU2014332191A1 (en) 2016-04-21
DK3054920T3 (da) 2021-03-29
ZA201601960B (en) 2017-08-30
BR112016007771B1 (pt) 2023-03-28
BR112016007771A2 (pl) 2017-08-01
KR102364945B1 (ko) 2022-02-17
WO2015054124A2 (en) 2015-04-16
EP3054920A2 (en) 2016-08-17
US20150099726A1 (en) 2015-04-09
US20160243320A1 (en) 2016-08-25
TW201542252A (zh) 2015-11-16
KR20160065204A (ko) 2016-06-08
US9066957B2 (en) 2015-06-30
WO2015054124A3 (en) 2015-09-03
TWI673070B (zh) 2019-10-01
CA2926432A1 (en) 2015-04-16
CL2016000735A1 (es) 2016-11-11
PH12016500619A1 (en) 2016-06-13
ES2863198T3 (es) 2021-10-08
CN105636630B (zh) 2020-05-19
CN105636630A (zh) 2016-06-01
PH12016500619B1 (en) 2016-06-13

Similar Documents

Publication Publication Date Title
IL272629A (en) Dry powder inhaler
IL244959B (en) Dry powder inhaler
AU351520S (en) Inhaler
GB201319150D0 (en) An inhaler
LT3019225T (lt) Inhaliatorius
AU352076S (en) Inhaler
ZA201703077B (en) Dry powder inhaler
GB2513553B (en) An Inhaler
IL257004B (en) Dry powder inhaler
PL3632373T3 (pl) Inhalator
SI3035886T1 (sl) Inhalator
ZA201508680B (en) Inhaler
GB201319144D0 (en) An Inhaler
GB201319152D0 (en) An Inhaler
GB201319145D0 (en) An inhaler
GB201319573D0 (en) Powder Inhaler Device
HU4880U (hu) Inhalátor
GB201303337D0 (en) Powder
GB201307202D0 (en) New compounds and uses